Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

      Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

      Medical Dialogues Bureau2 Dec 2019 3:35 PM IST
      Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys(Bengaluru-based subsidiary of...
      Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

      Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

      Medical Dialogues Bureau2 Dec 2019 9:35 AM IST
      Sibaji Biswas will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a...
      Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint

      Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint

      Medical Dialogues Bureau2 Dec 2019 9:30 AM IST
      SUVN-502 did not meet the pre-specified primary endpoint. Meaningful improvements and potential beneficial effects on cognitive function, behavioural...
      China plans to use bulk-buy scheme to close pharmaceutical price gap

      China plans to use bulk-buy scheme to close pharmaceutical price gap

      Medical Dialogues Bureau2 Dec 2019 9:00 AM IST
      New Delhi: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets,...
      Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug Controllers

      Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug Controllers

      Medical Dialogues Bureau1 Dec 2019 2:00 PM IST
      New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation (CDSCO) has informed all the State Drug Controllers about...
      Eli Lilly to invest USD 400 million in Indianapolis facilities

      Eli Lilly to invest USD 400 million in Indianapolis facilities

      Medical Dialogues Bureau1 Dec 2019 9:30 AM IST
      New Delhi: Eli Lilly and Company recently announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus...
      Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal

      Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal

      Medical Dialogues Bureau1 Dec 2019 9:00 AM IST
      Neuraxpharm aims to build its position as a CNS specialist in Portugal offering its wide portfolio of branded and consumer healthcare products in the...
      Health Ministry appoints 12 analysts pan India for different classes of drugs; Details

      Health Ministry appoints 12 analysts pan India for different classes of drugs; Details

      Medical Dialogues Bureau30 Nov 2019 2:58 PM IST
      New Delhi: Through a recent Gazette notification, the Union Health Ministry has announced the appointment of Government Analysts in pan India in...
      MTaI to work closely with DoP, Invest India to promote investments in medical device sector

      MTaI to work closely with DoP, Invest India to promote investments in medical device sector

      Medical Dialogues Bureau30 Nov 2019 12:42 PM IST
      "MTaI has been engaging with the Department of Pharmaceuticals and the Invest India team closely to work on several corrective measures which will...
      Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore

      Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore

      Medical Dialogues Bureau30 Nov 2019 9:45 AM IST
      Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company, Aurobindo Pharma said in...
      AstraZeneca cancer drug Imfinzi gets USFDA priority review

      AstraZeneca cancer drug Imfinzi gets USFDA priority review

      Medical Dialogues Bureau30 Nov 2019 9:40 AM IST
      AstraZeneca said the USFDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of previously untreated...
      Cipla shares jump 2 pc post agreement with CitiHealth Imports

      Cipla shares jump 2 pc post agreement with CitiHealth Imports

      Medical Dialogues Bureau30 Nov 2019 9:15 AM IST
      New Delhi: Shares of Cipla on Thursday rose nearly 2 per cent after the pharma major said its arm has signed an agreement with CitiHealth Imports to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok